OTC Capital Partners » Bristol Myers http://otccapitalpartners.com/b Your source for creative financing Thu, 09 Feb 2012 09:00:03 +0000 en hourly 1 http://wordpress.org/?v=3.3.1 Analysis: New Teva CEO to shift focus to branded drugs http://otccapitalpartners.com/b/analysis-new-teva-ceo-to-shift-focus-to-branded-drugs/ http://otccapitalpartners.com/b/analysis-new-teva-ceo-to-shift-focus-to-branded-drugs/#comments Tue, 03 Jan 2012 21:40:03 +0000 Reuters: Business News http://otccapitalpartners.com/b/analysis-new-teva-ceo-to-shift-focus-to-branded-drugs/ JERUSALEM (Reuters) – Teva Pharmaceutical Industries’ new chief executive is set to shift the company’s focus to branded drugs from generics as he imports a successful strategy of making mid-sized deals from Bristol-Myers Squibb.



Source >>>

]]> http://otccapitalpartners.com/b/analysis-new-teva-ceo-to-shift-focus-to-branded-drugs/feed/ 0 Data may prove Bristol and Pfizer drug a winner http://otccapitalpartners.com/b/data-may-prove-bristol-and-pfizer-drug-a-winner/ http://otccapitalpartners.com/b/data-may-prove-bristol-and-pfizer-drug-a-winner/#comments Mon, 22 Aug 2011 16:20:29 +0000 Reuters: Business News http://otccapitalpartners.com/b/data-may-prove-bristol-and-pfizer-drug-a-winner/ LONDON (Reuters) – Despite being third to market, a new bloodthinner from Bristol-Myers Squibb and Pfizer may become the biggest seller in an emerging multibillion-dollar class of drugs for preventing strokes in heart patients.



Source >>>

]]> http://otccapitalpartners.com/b/data-may-prove-bristol-and-pfizer-drug-a-winner/feed/ 0 Skin cancer drug news boosts Bristol shares http://otccapitalpartners.com/b/skin-cancer-drug-news-boosts-bristol-shares/ http://otccapitalpartners.com/b/skin-cancer-drug-news-boosts-bristol-shares/#comments Mon, 07 Jun 2010 17:10:29 +0000 Reuters: Business News http://otccapitalpartners.com/b/skin-cancer-drug-news-boosts-bristol-shares/ NEW YORK/LONDON (Reuters) – Bristol-Myers Squibb Co’s shares rose more than 8 percent on Monday after news over the weekend that its experimental drug ipilimumab extended survival in patients with deadly skin cancer.



Source >>>

]]> http://otccapitalpartners.com/b/skin-cancer-drug-news-boosts-bristol-shares/feed/ 0 Bristol sets baseline for profits post-Plavix http://otccapitalpartners.com/b/bristol-sets-baseline-for-profits-post-plavix/ http://otccapitalpartners.com/b/bristol-sets-baseline-for-profits-post-plavix/#comments Thu, 04 Mar 2010 13:31:03 +0000 Reuters: Business News http://otccapitalpartners.com/b/bristol-sets-baseline-for-profits-post-plavix/ NEW YORK (Reuters) – Bristol-Myers Squibb Co set a baseline for profits in 2013 as it provided investors their first glimpse of life after Plavix, the world’s second-bestselling drug.



Source >>>

]]> http://otccapitalpartners.com/b/bristol-sets-baseline-for-profits-post-plavix/feed/ 0